Natixis’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58.9K | Sell |
3,921
-102
| -3% | -$1.53K | ﹤0.01% | 846 |
|
|
2025
Q1 | $53K | Sell |
4,023
-332
| -8% | -$4.37K | ﹤0.01% | 802 |
|
|
2024
Q4 | $68.8K | Hold |
4,355
| – | – | ﹤0.01% | 851 |
|
|
2024
Q3 | $69.2K | Buy |
4,355
+1,520
| +54% | +$24.2K | ﹤0.01% | 756 |
|
|
2024
Q2 | $43.2K | Hold |
2,835
| – | – | ﹤0.01% | 779 |
|
|
2024
Q1 | $41.6K | Hold |
2,835
| – | – | ﹤0.01% | 813 |
|
|
2023
Q4 | $39.5K | Hold |
2,835
| – | – | ﹤0.01% | 823 |
|
|
2023
Q3 | $37.9K | Hold |
2,835
| – | – | ﹤0.01% | 827 |
|
|
2023
Q2 | $35.8K | Sell |
2,835
-720
| -20% | -$9.09K | ﹤0.01% | 853 |
|
|
2023
Q1 | $40.5K | Buy |
+3,555
| New | +$40.5K | ﹤0.01% | 834 |
|
|
2020
Q4 | – | Sell |
-196,000
| Closed | -$2.73M | – | 1096 |
|
|
2020
Q3 | $2.73M | Sell |
196,000
-389,110
| -67% | -$5.41M | 0.02% | 366 |
|
|
2020
Q2 | $6.2M | Sell |
585,110
-859,890
| -60% | -$9.12M | 0.05% | 256 |
|
|
2020
Q1 | $11.7M | Sell |
1,445,000
-666,300
| -32% | -$5.37M | 0.09% | 183 |
|
|
2019
Q4 | $17.2M | Sell |
2,111,300
-25,000
| -1% | -$204K | 0.11% | 206 |
|
|
2019
Q3 | $16.2M | Buy |
2,136,300
+28,075
| +1% | +$213K | 0.1% | 185 |
|
|
2019
Q2 | $15.8M | Buy |
+2,108,225
| New | +$15.8M | 0.12% | 161 |
|
|
2018
Q2 | – | Sell |
-34,885
| Closed | -$228K | – | 977 |
|
|
2018
Q1 | $228K | Buy |
+34,885
| New | +$228K | ﹤0.01% | 813 |
|
|
2017
Q4 | – | Sell |
-121,665
| Closed | -$868K | – | 1113 |
|
|
2017
Q3 | $868K | Buy |
+121,665
| New | +$868K | 0.01% | 534 |
|